Weight Loss Drugs May Risk Bone Health and Malnutrition
Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.